Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. & Walters, E. E.
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry
62, 617–627 (2005).
Why do you need to move beyond first-line therapy for major depression?
J. Clin. Psychiatry
71 (Suppl. 1), 4–9 (2010).
Conway, K. P., Compton, W., Stinson, F. S. & Grant, B. F.
Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on alcohol and related conditions. J. Clin. Psychiatry
67, 247–257 (2006).
Nestler, E. J. & Carlezon, W. A. Jr.
The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry
59, 1151–1159 (2006).
Koob, G. F. & Le Moal, M.
Addiction and the brain antireward system. Annu. Rev. Psychol.
59, 29–53 (2008).
Hnasko, T. S., Hjelmstad, G. O., Fields, H. L. & Edwards, R. H.
Ventral tegmental area glutamate neurons: electrophysiological properties and projections. J. Neurosci.
32, 15076–15085 (2012). This study provides compelling evidence that a subset of VTA projection neurons use glutamate as a neurotransmitter.
Tritsch, N. X., Ding, J. B. & Sabatini, B. L.
Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature
490, 262–266 (2012).
Ikemoto, S. & Wise, R. A.
Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area. J. Neurosci.
22, 9895–9904 (2002).
Potential vulnerabilities of neuronal reward, risk, and decision mechanisms to addictive drugs. Neuron
69, 603–617 (2011). This important review summarizes the complex role of dopaminergic systems in controlling reward.
Berridge, K. C. & Robinson, T. E.
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Brain Res. Brain Res. Rev.
28, 309–369 (1998).
Blakemore, S. J. & Robbins, T. W.
Decision-making in the adolescent brain. Nature Neurosci.
15, 1184–1191 (2012).
Sharp, C., Monterosso, J. & Montague, P. R.
Neuroeconomics: a bridge for translational research. Biol. Psychiatry
72, 87–92 (2012).
Sesack, S. R. & Grace, A. A.
Cortico-basal ganglia reward network: microcircuitry. Neuropsychopharmacology
35, 27–47 (2010).
Witten, I. B.
et al. Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron
72, 721–733 (2011). This paper describes the use of optogenetics to show that light stimulation of VTA dopamine neurons expressing ChR2 causes mice to self-stimulate those neurons, confirming that VTA dopamine neuron activity is indeed reinforcing.
Tan, K. R.
et al. GABA neurons of the VTA drive conditioned place aversion. Neuron
73, 1173–1183 (2012).
Tsai, H. C.
et al. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science
324, 1080–1084 (2009).
van Zessen, R., Phillips, J. L., Budygin, E. A. & Stuber, G. D.
Activation of VTA GABA neurons disrupts reward consumption. Neuron
73, 1184–1194 (2012).
Lobo, M. K.
et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science
330, 385–390 (2010).
Kravitz, A. V., Tye, L. D. & Kreitzer, A. C.
Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nature Neurosci.
15, 816–818 (2012).
Everitt, B. J. & Robbins, T. W.
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neurosci.
8, 1481–1489 (2005).
Witten, I. B.
et al. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science
330, 1677–1681 (2010).
Brown, M. T.
et al. Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning. Nature
492, 452–456 (2012). This paper identifies a GABAergic projection from the VTA that selectively innervates cholinergic interneurons in the NAc. Despite being a relatively minor (∼2%) component of all VTA projections, this pathway has a robust behavioural effect.
Yeomans, J. S., Kofman, O. & McFarlane, V.
Cholinergic involvement in lateral hypothalamic rewarding brain stimulation. Brain Res.
329, 19–26 (1985).
Britt, J. P.
et al. Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron
76, 790–803 (2012).
Chen, B. T.
et al. Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking. Nature
496, 359–362 (2013).
Pascoli, V., Turiault, M. & Luscher, C.
Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour. Nature
481, 71–75 (2012).
Stuber, G. D.
et al. Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature
475, 377–380 (2011).
Stamatakis, A. M. & Stuber, G. D.
Activation of lateral habenula inputs to the ventral midbrain promotes behavioral avoidance. Nature Neurosci.
15, 1105–1107 (2012).
Lammel, S., Ion, D. I., Roeper, J. & Malenka, R. C.
Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron
70, 855–862 (2012).
et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature
491, 212–217 (2012).
Bolanos, C. A.
et al. Phospholipase Cγ in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors. J. Neurosci.
23, 7569–7576 (2003).
Olson, V. G.
et al. Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J. Neurosci.
25, 5553–5562 (2005).
Savitz, J. & Drevets, W. C.
Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci. Biobehav. Rev.
33, 699–771 (2009).
Bremner, J. D.
et al. Hippocampal volume reduction in major depression. Am. J. Psychiatry
157, 115–118 (2000).
et al. White matter lesion volumes and caudate volumes in late-life depression. Int. J. Geriatr. Psychiatry
21, 1193–1198 (2006).
Husain, M. M.
et al. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res.
40, 95–99 (1991).
Krishnan, K. R.
et al. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch. Gen. Psychiatry
49, 553–557 (1992).
Drevets, W. C.
et al. A functional anatomical study of unipolar depression. J. Neurosci.
12, 3628–3641 (1992).
Mayberg, H. S.
et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry
48, 830–843 (2000).
Golden, S. A.
et al. Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nature Med.
19, 337–344 (2013). This paper identifies an epigenetic mechanism in the NAc of depressed humans that reduces the expression of the small GTPase RAC1. It further shows that stress reduces Rac1 expression through a similar mechanism in mice and is necessary and sufficient to induce depression-like changes in behaviour and excitatory synaptic plasticity.
Hickie, I. B.
et al. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J. Affect Disord.
98, 137–142 (2007).
von Gunten, A., Fox, N. C., Cipolotti, L. & Ron, M. A.
A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. J. Neuropsychiatry Clin. Neurosci.
12, 493–498 (2000).
et al. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J. Clin. Psychiatry
65, 492–499 (2004).
Sheline, Y. I., Gado, M. H. & Price, J. L.
Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport
9, 2023–2028 (1998).
McEwen, B. S.
Stress and hippocampal plasticity. Annu. Rev. Neurosci.
22, 105–122 (1999).
Sheline, Y. I.
et al. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry
50, 651–658 (2001).
Fu, C. H.
et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry
61, 877–889 (2004).
Siegle, G. J., Thompson, W., Carter, C. S., Steinhauer, S. R. & Thase, M. E.
Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol. Psychiatry
61, 198–209 (2007).
Vyas, A., Pillai, A. G. & Chattarji, S.
Recovery after chronic stress fails to reverse amygdaloid neuronal hypertrophy and enhanced anxiety-like behavior. Neuroscience
128, 667–673 (2004).
Caetano, S. C.
et al. Smaller cingulate volumes in unipolar depressed patients. Biol. Psychiatry
59, 702–706 (2006).
Drevets, W. C.
et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature
386, 824–827 (1997).
Lai, T., Payne, M. E., Byrum, C. E., Steffens, D. C. & Krishnan, K. R.
Reduction of orbital frontal cortex volume in geriatric depression. Biol. Psychiatry
48, 971–975 (2000).
Steffens, D. C., McQuoid, D. R., Welsh-Bohmer, K. A. & Krishnan, K. R.
Left orbital frontal cortex volume and performance on the Benton Visual Retention Test in older depressives and controls. Neuropsychopharmacology
28, 2179–2183 (2003).
Taylor Tavares, J. V.
et al. Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage
42, 1118–1126 (2008).
Mayberg, H. S.
Targeted electrode-based modulation of neural circuits for depression. J. Clin. Invest.
119, 717–725 (2009).
Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry
48, 766–777 (2000).
Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D. & Rachmanova, V. I.
Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res.
67, 269–275 (2004).
Kang, H. J.
et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nature Med.
18, 1413–1417 (2012). This study uses microarray analysis to demonstrate downregulation of numerous synapse-related genes in the dorsolateral PFC of depressed humans.
Campbell, S. & MacQueen, G.
The role of the hippocampus in the pathophysiology of major depression. J. Psychiatry Neurosci.
29, 417–426 (2004).
Campbell, S., Marriott, M., Nahmias, C. & MacQueen, G. M.
Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry
161, 598–607 (2004).
Czeh, B. & Lucassen, P. J.
What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?
Eur. Arch. Psychiatry Clin. Neurosci.
257, 250–260 (2007).
van Tol, M. J.
et al. Functional magnetic resonance imaging correlates of emotional word encoding and recognition in depression and anxiety disorders. Biol. Psychiatry
71, 593–602 (2012).
Kessler, R. C.
The effects of stressful life events on depression. Annu. Rev. Psychol.
48, 191–214 (1997).
Magarinos, A. M. & McEwen, B. S.
Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience
69, 89–98 (1995).
Donohue, H. S.
et al. Chronic restraint stress induces changes in synapse morphology in stratum lacunosum-moleculare CA1 rat hippocampus: a stereological and three-dimensional ultrastructural study. Neuroscience
140, 597–606 (2006).
Liu, R. J.
et al. Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol. Psychiatry
71, 996–1005 (2011).
Shansky, R. M., Hamo, C., Hof, P. R., McEwen, B. S. & Morrison, J. H.
Stress-induced dendritic remodeling in the prefrontal cortex is circuit specific. Cereb. Cortex
19, 2479–2484 (2009).
et al. Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb. Cortex
18, 1374–1383 (2008).
Sierra-Mercado, D., Padilla-Coreano, N. & Quirk, G. J.
Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology
36, 529–538 (2011).
Disner, S. G., Beevers, C. G., Haigh, E. A. & Beck, A. T.
Neural mechanisms of the cognitive model of depression. Nature Rev. Neurosci.
12, 467–477 (2011).
Leuner, B. & Shors, T. J.
Stress, anxiety, and dendritic spines: what are the connections?
Mitra, R., Jadhav, S., McEwen, B. S., Vyas, A. & Chattarji, S.
Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. Proc. Natl Acad. Sci. USA
102, 9371–9376 (2005).
Christoffel, D. J.
et al. IκB kinase regulates social defeat stress-induced synaptic and behavioral plasticity. J. Neurosci.
31, 314–321 (2011).
Muhammad, A., Carroll, C. & Kolb, B.
Stress during development alters dendritic morphology in the nucleus accumbens and prefrontal cortex. Neuroscience
216, 103–109 (2012).
Campioni, M. R., Xu, M. & McGehee, D. S.
Stress-induced changes in nucleus accumbens glutamate synaptic plasticity. J. Neurophysiol.
101, 3192–3198 (2009).
Schlaepfer, T. E.
et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology
33, 368–377 (2008). This study shows the potential for deep brain stimulation of reward structures, such as the NAc, in depression treatment.
et al. Inhibitory synaptic control of depression-like behavior in a nucleus accumbens microcircuit. Soc. Neurosci. Abstr.
Gill, K. M. & Grace, A. A.
Differential effects of acute and repeated stress on hippocampus and amygdala inputs to the nucleus accumbens shell. Int. J Neuropsychopharmacol.
Belujon, P., Patton, M. H. & Grace, A. A.
Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of Schizophrenia. Cereb. Cortex
et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell
131, 391–404 (2007).
Cao, J. L.
et al. Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action. J. Neurosci.
30, 16453–16458 (2010).
et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature
493, 532–536 (2013). This study uses circuit-specific optogenetics to confirm that increased phasic firing of VTA dopamine neurons projecting to the NAc has a role in in mediating stress susceptibility.
Brischoux, F., Chakraborty, S., Brierley, D. I. & Ungless, M. A.
Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc. Natl Acad. Sci. USA
106, 4894–4899 (2009).
Valenti, O., Gill, K. M. & Grace, A. A.
Different stressors produce excitation or inhibition of mesolimbic dopamine neuron activity: response alteration by stress pre-exposure. Eur. J. Neurosci.
35, 1312–1321 (2012).
Tye, K. M.
et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature
493, 537–541 (2013). Along with reference 82, this paper highlights the complexity of understanding reward function in depression. Although chronic social defeat stress induces dopamine firing to promote depression-like behaviour (reference 82), these authors find that chronic mild stress decreases dopamine firing to promote depression-like behaviour.
Kalivas, P. W.
The glutamate homeostasis hypothesis of addiction. Nature Rev. Neurosci.
10, 561–572 (2009).
Covington, H. E.
et al. Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J. Neurosci.
30, 16082–16090 (2011).
Christoffel, D. J.
et al. Glutamatergic microcircuits regulate stress-induced alterations in social behavior. Soc. Neurosci. Abstr.
Warner-Schmidt, J. L.
et al. Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proc. Natl Acad. Sci. USA
109, 11360–11365 (2012).
Zarate, C. A. Jr, Mathews, D. C. & Furey, M. L.
Human biomarkers of rapid antidepressant effects. Biol. Psychiatry
73, 1142–1155 (2013).
et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science
311, 864–868 (2006).
Eisch, A. J.
et al. Brain-derived neurotrophic factor in the ventral midbrain–nucleus accumbens pathway: a role in depression. Biol. Psychiatry
54, 994–1005 (2003).
Iniguez, S. D.
et al. Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates responses to stress. J. Neurosci.
30, 7652–7663 (2010).
Warren, B. L.
et al. Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood. J. Neurosci.
31, 10347–10358 (2011).
et al. AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol. Psychiatry
64, 691–700 (2008).
Duman, R. S. & Monteggia, L. M.
A neurotrophic model for stress-related mood disorders. Biol. Psychiatry
59, 1116–1127 (2006).
Pu, L., Liu, Q. S. & Poo, M. M.
BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nature Neurosci.
9, 605–607 (2006).
Miller, A. H.
Neuroendocrine and immune system interactions in stress and depression. Psychiatr. Clin. North Am.
21, 443–463 (1998).
Anisman, H. & Hayley, S.
Inflammatory factors contribute to depression and its comorbid conditions. Sci. Signal
5, pe45 (2012).
et al. Treatment with interferon-alpha (IFNα) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFNα-induced depressive and anxiety symptoms and immune activation. Mol. Psychiatry
6, 475–480 (2001).
Hayley, S., Scharf, J. & Anisman, H.
Central administration of murine interferon-α induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: a mini-review and original experiments. Brain Behav. Immun.
31, 115–127 (2013).
et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry
67, 446–457 (2010).
Koo, J. W. & Duman, R. S.
IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl Acad. Sci. USA
105, 751–756 (2008).
Hodes, G. E.
et al. Innate peripheral immune responses predispose mice to susceptibility to repeated social defeat stress. Soc. Neurosci. Abstr.
Koo, J. W., Russo, S. J., Ferguson, D., Nestler, E. J. & Duman, R. S.
Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl Acad. Sci. USA
107, 2669–2674 (2010).
Christoffel, D. J.
et al. Effects of inhibitor of κB kinase activity in the nucleus accumbens on emotional behavior. Neuropsychopharmacology
37, 2615–2623 (2012).
Russo, S. J.
et al. Nuclear factor κB signaling regulates neuronal morphology and cocaine reward. J. Neurosci.
29, 3529–3537 (2009).
Dietz, D. M.
et al. Rac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neurons. Nature Neurosci.
15, 891–896 (2012).
Narayanan, N. S., Guarnieri, D. J. & DiLeone, R. J.
Metabolic hormones, dopamine circuits, and feeding. Front. Neuroendocrinol.
31, 104–112 (2010).
Chuang, J. C.
et al. A β3-adrenergic–leptin–melanocortin circuit regulates behavioral and metabolic changes induced by chronic stress. Biol. Psychiatry
67, 1075–1082 (2011).
Lim, B. K., Huang, K. W., Grueter, B. A., Rothwell, P. E. & Malenka, R. C.
Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens. Nature
487, 183–189 (2012). This study provides evidence for a model in which chronic stress-induced increases in melanocortin signalling to the NAc, acting via melanocortin 4 receptors, selectively attenuate the strength of glutamatergic synapses on D1-type MSNs.
et al. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J. Neurosci.
28, 3071–3075 (2008).
et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nature Neurosci.
11, 752–753 (2008).
et al. Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression. Transl. Psychiatry
2, e83 (2012).
et al. Role of nuclear factor κB in ovarian hormone-mediated stress hypersensitivity in female mice. Biol. Psychiatry
65, 874–880 (2009).
Wilkinson, M. B.
et al. Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J. Neurosci.
29, 7820–7832 (2009).
Peter, C. J. & Akbarian, S.
Balancing histone methylation activities in psychiatric disorders. Trends Mol. Med.
17, 372–379 (2011).
Sun, H., Kennedy, P. J. & Nestler, E. J.
Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology
38, 124–137 (2012).
Zhang, T. Y. & Meaney, M. J.
Epigenetics and the environmental regulation of the genome and its function. Annu. Rev. Psychol.
61, 439–466 (2010).
Carlezon, W. A. Jr, Duman, R. S. & Nestler, E. J.
The many faces of CREB. Trends Neurosci.
28, 436–445 (2005).
Blendy, J. A.
The role of CREB in depression and antidepressant treatment. Biol. Psychiatry
59, 1144–1150 (2006).
Covington, H. E.
et al. A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron
71, 656–670 (2011). One of the first studies to establish an epigenetic-based mechanism for stress susceptibility versus resilience in the NAc. The authors show that chronic social defeat stress downregulates the HMTs G9a (also known as EHMT2) and GLP (also known as EHMT1) in the NAc, which promotes susceptibility via induction of BDNF–CREB signalling in this brain region.
McClung, C. A. & Nestler, E. J.
Regulation of gene expression and cocaine reward by CREB and ΔFosB. Nature Neurosci.
6, 1208–1215 (2003).
Wallace, D. L.
et al. CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nature Neurosci.
12, 200–209 (2009).
Bruchas, M. R., Land, B. B. & Chavkin, C.
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res.
1314, 44–55 (2010).
Chartoff, E. H.
et al. Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Mol. Pharmacol.
75, 704–712 (2009).
et al. CREB modulates excitability of nucleus accumbens neurons. Nature Neurosci.
9, 475–477 (2006).
Brown, T. E.
et al. A silent synapse-based mechanism for cocaine-induced locomotor sensitization. J. Neurosci.
31, 8163–8174 (2011).
et al. Serum response factor promotes resilience to chronic social stress through the induction of ΔFosB. J. Neurosci.
30, 14585–14592 (2010).
et al. ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nature Neurosci.
13, 745–752 (2010).
Wilkinson, M. B.
et al. A novel role of the WNT–dishevelled–GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J. Neurosci.
31, 9084–9092 (2011).
Borrelli, E., Nestler, E. J., Allis, C. D. & Sassone-Corsi, P.
Decoding the epigenetic language of neuronal plasticity. Neuron
60, 961–974 (2008).
et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nature Neurosci.
13, 1137–1143 (2009).
et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron
56, 517–529 (2007).
et al. Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron
69, 359–372 (2011).
Chandramohan, Y., Droste, S. K., Arthur, J. S. & Reul, J. M.
The forced swimming-induced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway. Eur. J. Neurosci.
27, 2701–2713 (2008).
Covington, H. E., Vialou, V. F., LaPlant, Q., Ohnishi, Y. N. & Nestler, E. J.
Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition. Neurosci. Lett.
493, 122–126 (2011).
Hunter, R. G., McCarthy, K. J., Milne, T. A., Pfaff, D. W. & McEwen, B. S.
Regulation of hippocampal H3 histone methylation by acute and chronic stress. Proc. Natl Acad. Sci. USA
106, 20912–20917 (2009).
Tsankova, N. M.
et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neurosci.
9, 519–525 (2006).
et al. Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B. J. Neurosci.
30, 7152–7167 (2010).
Covington, H. E.
et al. Antidepressant actions of histone deacetylase inhibitors. J. Neurosci.
29, 11451–11460 (2009).
Schmidt, E. F.
et al. Identification of the cortical neurons that mediate antidepressant responses. Cell
149, 1152–1163 (2012). The authors demonstrate that p11, a protein that promotes the activity of certain serotonin and several other G protein-coupled receptors, is required for antidepressant-like responses. This action is mediated not only by p11 action in the PFC but also in the NAc, as the authors demonstrated previously.
Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S. & Heintz, N.
MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell
151, 1417–1430 (2012).
Deecher, D., Andree, T. H., Sloan, D. & Schechter, L. E.
From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology
33, 3–17 (2008).
Joeyen-Waldorf, J., Edgar, N. & Sibille, E.
The roles of sex and serotonin transporter levels in age- and stress-related emotionality in mice. Brain Res.
1286, 84–93 (2009).
Blehar, M. C.
Women's mental health research: the emergence of a biomedical field. Annu. Rev. Clin. Psychol.
2, 135–160 (2006).
Young, E. & Korszun, A.
Sex, trauma, stress hormones and depression. Mol. Psychiatry
15, 23–28 (2010).
Bless, E. P., McGinnis, K. A., Mitchell, A. L., Hartwell, A. & Mitchell, J. B.
The effects of gonadal steroids on brain stimulation reward in female rats. Behav. Brain Res.
82, 235–244 (1997).
Golden, S. A., Covington, H. E., Berton, O. & Russo, S. J.
A standardized protocol for repeated social defeat stress in mice. Nature Protoc.
6, 1183–1191 (2011).
Warren, B. L.
et al. Neurobiological sequelae of witnessing stressful events in adult mice. Biol. Psychiatry
73, 7–14 (2012).
Hill, M. N., Hellemans, K. G., Verma, P., Gorzalka, B. B. & Weinberg, J.
Neurobiology of chronic mild stress: parallels to major depression. Neurosci. Biobehav. Rev.
36, 2085–2117 (2012).
Trainor, B. C.
et al. Sex differences in social interaction behavior following social defeat stress in the monogamous California mouse (Peromyscus californicus). PLoS ONE
6, e17405 (2012). This important study establishes the utility of the chronic social defeat stress paradigm in female mice, using a different mouse species. Interestingly, the authors show some similar molecular abnormalities in the female NAc (increased CREB activity) as shown by other groups in males.
Maier, S. F. & Watkins, L. R.
Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav. Rev.
29, 829–841 (2005).
Der-Avakian, A. & Markou, A.
The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci.
35, 68–77 (2012).
Dalla, C., Pitychoutis, P. M., Kokras, N. & Papadopoulou-Daifoti, Z.
Sex differences in animal models of depression and antidepressant response. Basic Clin. Pharmacol. Toxicol.
106, 226–233 (2010).
Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology
52, 90–110 (2005).
Carlezon, W. A. Jr & Chartoff, E. H.
Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nature Protoc.
2, 2987–2995 (2007).
et al. Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology
62, 167–176 (2012).
Baliki, M. N.
et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nature Neurosci.
15, 1117–1119 (2012).
Scott, D. J.
et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry
65, 220–231 (2008).
Niikura, K., Narita, M., Butelman, E. R., Kreek, M. J. & Suzuki, T.
Neuropathic and chronic pain stimuli downregulate central μ-opioid and dopaminergic transmission. Trends Pharmacol. Sci.
31, 299–305 (2010).
et al. An essential role for ΔFosB in the nucleus accumbens in morphine action. Nature Neurosci.
9, 205–211 (2006).
Han, M. H.
et al. Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia. Biol. Psychiatry
67, 761–769 (2010).
et al. Regulator of G protein signaling is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proc. Natl Acad. Sci. USA
110, 8254–8259 (2013). This study demonstrates that the G protein regulatory protein RGS4, acting in the NAc, promotes therapeutic-like responses to standard monoamine-dependent antidepressants. By contrast, RGS4 opposes the antidepressant-like actions of non-monoamine-based drugs such as ketamine.
Kennedy, P. J.
et al. Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation. Nature Neurosci.
16, 434–440 (2013).